#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4603233	B	Inhibition of recombinant human full-length N-terminal GST-tagged p110delta/untagged full-length p85alpha expressed in baculovirus infected Sf21 cells using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	Homo sapiens	25		cell-based format	Scientific Literature
2.	ALA4603234	B	Selectivity index, ratio IC50 for inhibition of recombinant human full-length N-terminal His6-tagged p110alpha/untagged full-length p85alpha expressed in baculovirus infected Sf21 cells to ratio IC50 for inhibition of recombinant human full-length N-terminal GST-tagged p110delta/untagged full-length p85alpha expressed in baculovirus infected Sf21 cells	Homo sapiens	24		cell-based format	Scientific Literature
3.	ALA4603235	B	Selectivity index, ratio IC50 for inhibition of recombinant human full-length N-terminal His6-tagged p110beta/untagged full-length p85alpha expressed in baculovirus infected Sf21 cells to ratio IC50 for inhibition of recombinant human full-length N-terminal GST-tagged p110delta/untagged full-length p85alpha expressed in baculovirus infected Sf21 cells	Homo sapiens	24		cell-based format	Scientific Literature
4.	ALA4603236	B	Selectivity index, ratio IC50 for inhibition of recombinant human N-terminal His6-tagged full-length p120gamma expressed in Sf21 insect cells to ratio IC50 for inhibition of recombinant human full-length N-terminal GST-tagged p110delta/untagged full-length p85alpha expressed in baculovirus infected Sf21 cells	Homo sapiens	24		cell-based format	Scientific Literature
5.	ALA4603237	B	Inhibition of PI3K delta in human whole blood assessed as inhibition of anti-IgE-stimulated CysLt release in basophils preincubated for 30 mins followed by anti-IgE stimulation and measured after 20 mins	Homo sapiens	17		tissue-based format	Scientific Literature
6.	ALA4603238	P	Distribution coefficient, logD of compound by HPLC analysis		24		small-molecule physicochemical format	Scientific Literature
7.	ALA4603239	A	Clearance in rat liver microsomes	Rattus norvegicus	16		microsome format	Scientific Literature
8.	ALA4603240	A	Clearance in human liver microsomes	Homo sapiens	16		microsome format	Scientific Literature
9.	ALA4603246	A	Clearance in rat plasma at 0.5 mg/kg, iv or 1 mg/kg, po	Rattus norvegicus	1		organism-based format	Scientific Literature
10.	ALA4603247	A	Unbound clearance in rat at 0.5 mg/kg, iv or 1 mg/kg, po	Rattus norvegicus	1		organism-based format	Scientific Literature
11.	ALA4603248	A	Volume of drug distribution in rat at 0.5 mg/kg, iv or 1 mg/kg, po	Rattus norvegicus	1		organism-based format	Scientific Literature
12.	ALA4603249	A	Half life in rat at 0.5 mg/kg, iv 1 mg/kg, po	Rattus norvegicus	1		organism-based format	Scientific Literature
13.	ALA4603250	A	Oral bioavailability in rat at 0.5 mg/kg	Rattus norvegicus	1		organism-based format	Scientific Literature
14.	ALA4603251	A	Protein binding in rat plasma at 0.5 mg/kg, iv or 1 mg/kg, po	Rattus norvegicus	1		organism-based format	Scientific Literature
15.	ALA4603252	A	Clearance in dog plasma at 0.5 mg/kg, iv or 1 mg/kg, po	Canis lupus familiaris	1		organism-based format	Scientific Literature
16.	ALA4603253	A	Unbound clearance in dog at 0.5 mg/kg, iv or 1 mg/kg, po	Canis lupus familiaris	1		organism-based format	Scientific Literature
17.	ALA4603254	A	Volume of drug distribution in dog at 0.5 mg/kg, iv or 1 mg/kg, po	Canis lupus familiaris	1		organism-based format	Scientific Literature
18.	ALA4603255	A	Half life in dog at 0.5 mg/kg, iv 1 mg/kg, po	Canis lupus familiaris	1		organism-based format	Scientific Literature
19.	ALA4603256	A	Oral bioavailability in dog at 0.5 mg/kg	Canis lupus familiaris	1		organism-based format	Scientific Literature
20.	ALA4603257	A	Protein binding in dog plasma at 0.5 mg/kg, iv or 1 mg/kg, po	Canis lupus familiaris	1		organism-based format	Scientific Literature